TY - JOUR AU - Sadelain, M. PY - 2017 DA - 2017// TI - CD19 CAR T cells JO - Cell VL - 171 UR - https://doi.org/10.1016/j.cell.2017.12.002 DO - 10.1016/j.cell.2017.12.002 ID - Sadelain2017 ER - TY - JOUR AU - Urbanska, K. AU - Lanitis, E. AU - Poussin, M. AU - Lynn, R. C. AU - Gavin, B. P. AU - Kelderman, S. PY - 2012 DA - 2012// TI - A universal strategy for adoptive immunotherapy of Cancer through use of a novel T-cell antigen receptor JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3890 DO - 10.1158/0008-5472.CAN-11-3890 ID - Urbanska2012 ER - TY - JOUR AU - Tamada, K. AU - Geng, D. AU - Sakoda, Y. AU - Bansal, N. AU - Srivastava, R. AU - Li, Z. PY - 2012 DA - 2012// TI - Redirecting gene-modified T cells toward various Cancer types using tagged antibodies JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1449 DO - 10.1158/1078-0432.CCR-12-1449 ID - Tamada2012 ER - TY - JOUR AU - Cho, J. H. AU - Collins, J. J. AU - Wong, W. W. PY - 2018 DA - 2018// TI - Universal chimeric antigen receptors for multiplexed and logical control of T cell responses JO - Cell VL - 173 UR - https://doi.org/10.1016/j.cell.2018.03.038 DO - 10.1016/j.cell.2018.03.038 ID - Cho2018 ER - TY - JOUR AU - Darowski, D. AU - Kobold, S. AU - Jost, C. AU - Klein, C. PY - 2019 DA - 2019// TI - Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells JO - MAbs VL - 11 UR - https://doi.org/10.1080/19420862.2019.1596511 DO - 10.1080/19420862.2019.1596511 ID - Darowski2019 ER - TY - JOUR AU - Bachmann, M. PY - 2019 DA - 2019// TI - The UniCAR system: a modular CAR T cell approach to improve the safety of CAR T cells JO - Immunol Lett VL - 211 UR - https://doi.org/10.1016/j.imlet.2019.05.003 DO - 10.1016/j.imlet.2019.05.003 ID - Bachmann2019 ER - TY - JOUR AU - Koristka, S. AU - Cartellieri, M. AU - Feldmann, A. AU - Arndt, C. AU - Loff, S. AU - Michalk, I. PY - 2014 DA - 2014// TI - Flexible antigen-specific redirection of human regulatory T cells via a novel universal chimeric antigen receptor system JO - Blood VL - 124 UR - https://doi.org/10.1182/blood.V124.21.3494.3494 DO - 10.1182/blood.V124.21.3494.3494 ID - Koristka2014 ER - TY - JOUR AU - Cartellieri, M. AU - Feldmann, A. AU - Koristka, S. AU - Arndt, C. AU - Loff, S. AU - Ehninger, A. PY - 2016 DA - 2016// TI - Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts JO - Blood Cancer J VL - 6 UR - https://doi.org/10.1038/bcj.2016.61 DO - 10.1038/bcj.2016.61 ID - Cartellieri2016 ER - TY - JOUR AU - Feldmann, A. AU - Arndt, C. AU - Bergmann, R. AU - Loff, S. AU - Cartellieri, M. AU - Bachmann, D. PY - 2017 DA - 2017// TI - Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR” JO - Oncotarget VL - 8 ID - Feldmann2017 ER - TY - JOUR AU - Albert, S. AU - Arndt, C. AU - Feldmann, A. AU - Bergmann, R. AU - Bachmann, D. AU - Koristka, S. PY - 2017 DA - 2017// TI - A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform JO - Oncoimmunology VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1287246 DO - 10.1080/2162402X.2017.1287246 ID - Albert2017 ER - TY - JOUR AU - Mitwasi, N. AU - Feldmann, A. AU - Bergmann, R. AU - Berndt, N. AU - Arndt, C. AU - Koristka, S. PY - 2017 DA - 2017// TI - Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.21017 DO - 10.18632/oncotarget.21017 ID - Mitwasi2017 ER - TY - JOUR AU - Loureiro, L. R. AU - Feldmann, A. AU - Bergmann, R. AU - Koristka, S. AU - Berndt, N. AU - Arndt, C. PY - 2018 DA - 2018// TI - Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells JO - Blood Cancer J VL - 8 UR - https://doi.org/10.1038/s41408-018-0113-4 DO - 10.1038/s41408-018-0113-4 ID - Loureiro2018 ER - TY - JOUR AU - Victorzon, M. AU - Nordling, S. AU - Nilsson, O. AU - Roberts, P. J. AU - Haglund, C. PY - 1996 DA - 1996// TI - Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer JO - Int J Cancer VL - 65 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Victorzon1996 ER - TY - JOUR AU - Itzkowitz, S. H. AU - Bloom, E. J. AU - Kokal, W. A. AU - Modin, G. AU - Hakomori, S. AU - Kim, Y. S. PY - 1990 DA - 1990// TI - Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients JO - Cancer VL - 66 UR - https://doi.org/3.0.CO;2-X DO - 3.0.CO;2-X ID - Itzkowitz1990 ER - TY - JOUR AU - Kobayashi, H. AU - Terao, T. AU - Kawashima, Y. PY - 1992 DA - 1992// TI - Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer JO - J Clin Oncol VL - 10 UR - https://doi.org/10.1200/JCO.1992.10.1.95 DO - 10.1200/JCO.1992.10.1.95 ID - Kobayashi1992 ER - TY - JOUR AU - Leivonen, M. AU - Nordling, S. AU - Lundin, J. AU - Boguslawski, K. AU - Haglund, C. PY - 2001 DA - 2001// TI - STn and prognosis in breast cancer JO - Oncology VL - 61 UR - https://doi.org/10.1159/000055337 DO - 10.1159/000055337 ID - Leivonen2001 ER - TY - JOUR AU - Ferreira, J. A. AU - Videira, P. A. AU - Lima, L. AU - Pereira, S. AU - Silva, M. AU - Carrascal, M. PY - 2013 DA - 2013// TI - Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours JO - Mol Oncol VL - 7 UR - https://doi.org/10.1016/j.molonc.2013.03.001 DO - 10.1016/j.molonc.2013.03.001 ID - Ferreira2013 ER - TY - JOUR AU - Julien, S. AU - Adriaenssens, E. AU - Ottenberg, K. AU - Furlan, A. AU - Courtand, G. AU - Vercoutter-Edouart, A. S. PY - 2006 DA - 2006// TI - ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity JO - Glycobiology VL - 16 UR - https://doi.org/10.1093/glycob/cwj033 DO - 10.1093/glycob/cwj033 ID - Julien2006 ER - TY - JOUR AU - Pinho, S. AU - Marcos, N. T. AU - Ferreira, B. AU - Carvalho, A. S. AU - Oliveira, M. J. AU - Santos-Silva, F. PY - 2007 DA - 2007// TI - Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells JO - Cancer Lett VL - 249 UR - https://doi.org/10.1016/j.canlet.2006.08.010 DO - 10.1016/j.canlet.2006.08.010 ID - Pinho2007 ER - TY - JOUR AU - Munkley, J. PY - 2016 DA - 2016// TI - The role of sialyl-Tn in cancer JO - Int J Mol Sci VL - 17 UR - https://doi.org/10.3390/ijms17030275 DO - 10.3390/ijms17030275 ID - Munkley2016 ER - TY - JOUR AU - Julien, S. AU - Krzewinski-Recchi, M. A. AU - Harduin-Lepers, A. AU - Gouyer, V. AU - Huet, G. AU - Bourhis, X. PY - 2001 DA - 2001// TI - Expression of Sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc α2,6-sialyltransferase (ST6GalNAc I) cDNA JO - Glycoconj J VL - 18 UR - https://doi.org/10.1023/A:1022200525695 DO - 10.1023/A:1022200525695 ID - Julien2001 ER - TY - JOUR AU - Arndt, C. AU - Feldmann, A. AU - Bonin, M. AU - Cartellieri, M. AU - Ewen, E. AU - Koristka, S. PY - 2014 DA - 2014// TI - Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33 : description of a novel modular targeting system JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2013.243 DO - 10.1038/leu.2013.243 ID - Arndt2014 ER - TY - JOUR AU - Feldmann, A. AU - Arndt, C. AU - Topfer, K. AU - Stamova, S. AU - Krone, F. AU - Cartellieri, M. PY - 2012 DA - 2012// TI - Novel humanized and highly efficient Bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells JO - J Immunol VL - 189 UR - https://doi.org/10.4049/jimmunol.1200341 DO - 10.4049/jimmunol.1200341 ID - Feldmann2012 ER - TY - JOUR AU - Arndt, C. AU - Feldmann, A. AU - Koristka, S. AU - Cartellieri, M. AU - Dimmel, M. AU - Ehninger, A. PY - 2014 DA - 2014// TI - Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system JO - Prostate VL - 74 UR - https://doi.org/10.1002/pros.22850 DO - 10.1002/pros.22850 ID - Arndt2014 ER - TY - JOUR AU - Cartellieri, M. AU - Koristka, S. AU - Arndt, C. AU - Feldmann, A. AU - Stamova, S. AU - Bonin, M. PY - 2014 DA - 2014// TI - A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0093745 DO - 10.1371/journal.pone.0093745 ID - Cartellieri2014 ER - TY - JOUR AU - Feldmann, A. AU - Stamova, S. AU - Bippes, C. C. AU - Bartsch, H. AU - Wehner, R. AU - Schmitz, M. PY - 2011 DA - 2011// TI - Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats JO - Prostate VL - 71 UR - https://doi.org/10.1002/pros.21315 DO - 10.1002/pros.21315 ID - Feldmann2011 ER - TY - JOUR AU - David, T. AU - Hlinová, V. AU - Kubíček, V. AU - Bergmann, R. AU - Striese, F. AU - Berndt, N. PY - 2018 DA - 2018// TI - Improved conjugation, 64-cu radiolabeling, in vivo stability, and imaging using nonprotected Bifunctional macrocyclic ligands: Bis (Phosphinate) Cyclam (BPC) Chelators JO - J Med Chem VL - 61 UR - https://doi.org/10.1021/acs.jmedchem.8b00932 DO - 10.1021/acs.jmedchem.8b00932 ID - David2018 ER - TY - JOUR AU - Loureiro, L. R. AU - Sousa, D. P. AU - Ferreira, D. AU - Chai, W. AU - Lima, L. AU - Pereira, C. PY - 2018 DA - 2018// TI - Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-30421-w DO - 10.1038/s41598-018-30421-w ID - Loureiro2018 ER - TY - JOUR AU - Johnson, D. E. PY - 2018 DA - 2018// TI - Biotherapeutics: challenges and opportunities for predictive toxicology of monoclonal antibodies JO - Int J Mol Sci VL - 19 UR - https://doi.org/10.3390/ijms19113685 DO - 10.3390/ijms19113685 ID - Johnson2018 ER - TY - JOUR AU - Dumet, C. AU - Pottier, J. AU - Gouilleux-Gruart, V. AU - Watier, H. PY - 2019 DA - 2019// TI - Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development JO - MAbs VL - 11 UR - https://doi.org/10.1080/19420862.2019.1664365 DO - 10.1080/19420862.2019.1664365 ID - Dumet2019 ER - TY - JOUR AU - Kulemzin, S. V. AU - Kuznetsova, V. V. AU - Mamonkin, M. AU - Taranin, A. V. AU - Gorchakov, A. A. PY - 2017 DA - 2017// TI - Engineering chimeric antigen receptors JO - Acta Nat VL - 9 UR - https://doi.org/10.32607/20758251-2017-9-1-6-14 DO - 10.32607/20758251-2017-9-1-6-14 ID - Kulemzin2017 ER - TY - JOUR AU - Rodgers, D. T. AU - Mazagova, M. AU - Hampton, E. N. AU - Cao, Y. AU - Ramadoss, N. S. AU - Hardy, I. R. PY - 2016 DA - 2016// TI - Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies JO - Proc Natl Acad Sci U S A VL - 113 UR - https://doi.org/10.1073/pnas.1524155113 DO - 10.1073/pnas.1524155113 ID - Rodgers2016 ER - TY - JOUR AU - Ochi, F. AU - Fujiwara, H. AU - Tanimoto, K. AU - Asai, H. AU - Miyazaki, Y. AU - Okamoto, S. PY - 2014 DA - 2014// TI - Gene-modified human α/β-T cells expressing a chimeric CD16-CD3ζ receptor as adoptively transferable effector cells for anticancer monoclonal antibody therapy JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-13-0099-T DO - 10.1158/2326-6066.CIR-13-0099-T ID - Ochi2014 ER - TY - JOUR AU - Tanaka, H. AU - Fujiwara, H. AU - Ochi, F. AU - Tanimoto, K. AU - Casey, N. AU - Okamoto, S. PY - 2016 DA - 2016// TI - Development of engineered T cells expressing a chimeric CD16-CD3 receptor to improve the clinical efficacy of Mogamulizumab therapy against adult T-cell leukemia JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-2714 DO - 10.1158/1078-0432.CCR-15-2714 ID - Tanaka2016 ER - TY - JOUR AU - Casneuf, T. AU - Axel, A. E. AU - King, P. AU - Alvarez, J. D. AU - Werbeck, J. L. AU - Verhulst, T. PY - 2016 DA - 2016// TI - Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer JO - Breast Cancer VL - 8 ID - Casneuf2016 ER - TY - JOUR AU - Severino, P. F. AU - Silva, M. AU - Carrascal, M. AU - Malagolini, N. AU - Chiricolo, M. AU - Venturi, G. PY - 2017 DA - 2017// TI - Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage JO - Oncotarget VL - 8 ID - Severino2017 ER - TY - JOUR AU - Eavarone, D. A. AU - Rao, P. E. AU - Prendergast, J. M. AU - Curtis, A. D. AU - Zhang, R. AU - Shopland, L. S. PY - 2018 DA - 2018// TI - Abstract 5625: myeloid derived suppressor cells (MDSCs) express Sialyl Tn (STn) and are a therapeutic target for anti-STn antibody drug conjugates JO - Clin Res VL - 78 ID - Eavarone2018 ER - TY - JOUR AU - Pyzik, M. AU - Rath, T. AU - Lencer, W. I. AU - Baker, K. AU - Blumberg, R. S. PY - 2015 DA - 2015// TI - FcRn: the architect behind the immune and nonimmune functions of IgG and albumin JO - J Immunol VL - 194 UR - https://doi.org/10.4049/jimmunol.1403014 DO - 10.4049/jimmunol.1403014 ID - Pyzik2015 ER - TY - JOUR AU - Soares, R. AU - Marinho, A. AU - Schmitt, F. PY - 1996 DA - 1996// TI - Expression of sialyl-Tn in breast cancer: correlation with prognostic parameters JO - Pathol Res Pract VL - 192 UR - https://doi.org/10.1016/S0344-0338(96)80148-8 DO - 10.1016/S0344-0338(96)80148-8 ID - Soares1996 ER - TY - JOUR AU - Schultz, M. J. AU - Swindall, A. F. AU - Bellis, S. L. PY - 2012 DA - 2012// TI - Regulation of the metastatic cell phenotype by sialylated glycans JO - Cancer Metastasis Rev VL - 31 UR - https://doi.org/10.1007/s10555-012-9359-7 DO - 10.1007/s10555-012-9359-7 ID - Schultz2012 ER - TY - JOUR AU - Carrascal, M. A. AU - Severino, P. F. AU - Guadalupe Cabral, M. AU - Silva, M. AU - Ferreira, J. A. AU - Calais, F. PY - 2014 DA - 2014// TI - Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells JO - Mol Oncol VL - 8 UR - https://doi.org/10.1016/j.molonc.2014.02.008 DO - 10.1016/j.molonc.2014.02.008 ID - Carrascal2014 ER -